-
Using Scaling Factor Model to Estimate the Value Set of Psoriasis Bolt-On EQ-5D-5L Health States
Jun 10, 2025, 14:01 PM -
Trends in the Incorporation of Clinical Outcome Assessments in Asthma Drug Development in Japan: A Five-Year Review (2020-2024)
Jun 10, 2025, 14:01 PM -
Evaluating Fertility Treatment Costs in Japan: A Micro-Costing Analysis
Jun 10, 2025, 14:01 PM -
How Can We Enhance the Use of RWE in Reimbursement Decisions? Best Practices and Recommendations
Jun 10, 2025, 14:01 PM -
Sex Differences in Onset and Prevalence of 108 Diseases and Multimorbidity Across Lifespan in China: Quantitative Analysis of Real-World Linked Electronic Health Records
Jun 10, 2025, 14:01 PM -
Use of RWE to Inform Survival Extrapolation in Health Economic Appraisals of Cancer Drugs in Sweden: A Review of National Health Economic Reports 2010-2024
Jun 10, 2025, 14:01 PM -
Association Between Barriers to Accessing General Practitioners and Emergency Department Visits in New Zealand
Jun 10, 2025, 14:01 PM -
Will Training Enhance Antimicrobial Stewardship Implementation in Community Pharmacy? Bridging Gap Through a CPD Program
Jun 10, 2025, 14:01 PM -
Potential Risk of Acute Pancreatitis With GLP-1 Receptor Agonists
Jun 10, 2025, 14:01 PM -
Prescription Trends for ADHD Medications in Japan, 2018-2023
Jun 10, 2025, 14:01 PM -
Incorporating Real-World Evidence Into Time-to-Event Extrapolations From Clinical Trial Data
Jun 10, 2025, 14:01 PM -
Real-World Utilization, Persistence, and Effectiveness of Biologic Therapies in Patients With Severe Asthma: A Multicenter Retrospective Cohort Study in Taiwan
Jun 10, 2025, 14:01 PM -
An EQ-5D Multilayered Measure of Health-Related Quality of Life: Is There Relevance and Need for It?
Jun 10, 2025, 14:01 PM -
Integrating Real World Evidence in Economic Evaluation of Herpes Zoster Vaccination Among Kidney Transplant Patients in Thailand
Jun 10, 2025, 14:01 PM -
Real-World Effectiveness of Atezolizumab-Bevacizumab, Lenvatinib and Sorafenib in the Patients With Unresectable Hepatocellular Carcinoma: A Multi-institutional Study in Taiwan
Jun 10, 2025, 14:01 PM -
Research on the Driving Mechanism of Corporate Participation in Governance for Health—An Empirical Analysis Based on Chinese Listed Companies
Jun 10, 2025, 14:01 PM -
Incorporating Real-World Data and Mathematical Modeling to Estimate the Undiagnosed Chronic Hepatitis B Population
Jun 10, 2025, 14:01 PM -
Accessing the Risks: Decision-Making Uncertainty and RWE in Australian Market Access
Jun 10, 2025, 14:01 PM -
Patient Voices in Health Technology Assessments: Insights From Australia and Singapore
Jun 10, 2025, 14:01 PM -
Assessing Early Adoption of Pulsed Field Ablation for the Treatment of Atrial Fibrillation Using Claims and Hospital Charge Data
Jun 10, 2025, 14:01 PM